• Home
  • Investing
  • About
  • Contact
Menu

Economix101

  • Home
  • Investing
  • About
  • Contact
TeslaLogo.jpg

Tesla Uncoils For A Momentous Ride

March 10, 2014

Tesla

Tesla (TSLA) is a revolutionary electric car company based out of Palo Alto, California. The company was founded, and is now overseen, by billionaire entrepreneur Elon Musk. Tesla’s stock has grown by 600% over the past year, but has also been quite volatile. Interestingly, Tesla’s product portfolio contains only a single car: the Model S. However, it has been built with extreme expertise and was named Motor Trend’s Car of the Year for 2013. This reputation has encouraged Musk to further expand Tesla’s production, and potentially enter the energy sector. And much like the revolutionary car it builds, Tesla has announced plans to build a new state of the art factory (possibly in Texas); this would help Tesla pursue foreign markets, specifically those of China and Western Europe. Such plans, in addition to Silicon Valley investor momentum, paint a bright future for the company.

Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD) is a biopharmaceutical company that was founded in 1993, and based out of New York; they specialize in curing neurological diseases. Acadia’s current focus is on a new developmental drug, called Pima, which could help cure Parkinson’s disease psychosis. The drug has shown great success in initial clinical studies and has moved into phase III development. There are also indications that the drug may have more diverse applications, and may be involved in curing other mental health disorders. These promising signs lead to Acadia’s seeking FDA approval for their drug this year, given they pass their phase III trial. Some estimates place initial potential sales of Pima at $2 billion. Given Pima’s inevitable success, we assume Acadia’s revenues will eventually surpass $2 billion in the coming years. As Acadia nears official FDA approval for Pima, it would be wise to keep an eye on the momentum of this stock.

Disney

The Walt Disney Company (DIS) has forever been an American household name, and now it’s also a stock you should consider investing in. The company is one of the largest and most popular players in the entertainment industry. With assets such as Pixar Studios, ABC Company, and most notably ESPN, there is no secret as to why Disney continues to grow (posting a 7% increase in revenue last quarter). ESPN is nearly unstoppable given its monopoly over the sports entertainment industry. Additionally, the company also purchased LucasArts, and now owns the rights to the Star Wars franchise, several amusement parks, and more worldwide resorts. Although the stock may not be a bull in the short-term, it’s a favorable long-term position (see a more qualitative analysis of Disney here).

Citigroup

Citigroup (C) is the third largest bank operating in North America. It also operates in over 100 nations, demonstrating a formidable global presence. This reach is greater than any of Citigroup’s competitors, which gives it a favorable edge. In addition, Citigroup trades at a low price, $49.86, compared to similar banks like J.P. Morgan Chase & Co. and PNC Financial Services Group. Citi has come a long way since it received three government bailouts. The company had experienced colossal growth until it collapsed in the 2008 Financial Crisis. Since then, Citigroup has been on a steady rise under C.E.O. Michael Corbat, who has been with the company since 1983 and has decades of banking experience.

Qualcomm

Qualcomm (QCOM) is responsible for the majority of hardware chips used in today’s electronics, specifically smartphones. Their chips can be found in both Android and Apple devices. The company brought in $8.78 billion last year and returned billions to shareholders in the form of dividends. The smartphone industry is constantly evolving, and Qualcomm remains at the forefront. Although telecommunications hardware is a very competitive market, Qualcomm is a true and tested company. Its large cash flows allow for increased expenditures on R&D testing. These expenditures, although costly in the short-term, will most likely have long-term benefits.

Disclaimer: I do not currently own shares of Acadia, Tesla, Disney, Citigroup, or Qualcomm, nor do I plan to purchase any in the next 72 hours. The only compensation I receive for my articles is from Economix101, Inc.

In Manufacturing, Tech, Biotech, Finance, Entertainment, Advice, Stock Market Tags Tesla, Disney, Qualcomm, Citigroup, Acadia, Cars, Medicine, Banks, Stocks
← Raise The Bar, Raise The FlagGoPro To IPO →

Show Your Support

Please help us achieve worldwide financial literacy. Everyone deserves an economic education; follow and share our content across social media so that we aren't forced to advertise. Thanks.

Make & save money with Wealthfront.

Home RSS
Trending Authors
  • Jackson Moses
  • Ryan Vertelney
  • Zac Cherin
  • Spencer Drazovich
  • Jacob Grant

Trending Articles

Home
Dear World, LinkedIn Is Not Facebook
Dear World, LinkedIn Is Not Facebook
about 9 years ago
15 Reasons To Love Alibaba Stock
15 Reasons To Love Alibaba Stock
about 9 years ago
You're Missing Out On $100,000s
You're Missing Out On $100,000s
about 9 years ago
Building America's Next Bomber
Building America's Next Bomber
about 9 years ago
Uber Beats Facebook To $50B Valuation
Uber Beats Facebook To $50B Valuation
about 9 years ago
Marshawn Lynch Stars In Black Ops
Marshawn Lynch Stars In Black Ops
about 9 years ago
Taylor Swift & Apple Have Bad Blood
Taylor Swift & Apple Have Bad Blood
about 9 years ago
Netflix Is On Fire
Netflix Is On Fire
about 9 years ago
Who Actually Owns Jack Daniels?
Who Actually Owns Jack Daniels?
about 9 years ago
America's Most Secretive Company
America's Most Secretive Company
about 10 years ago

Home RSS

Brief Disclaimer: Economix101, Inc. is not an officially licensed analyst/research firm; moreover, investing is a risky endeavor. There is no guarantee that you will make money. There is a very real chance that you will lose money. This site, and its many contents, is to be used as an investment research tool, and nothing more. Please consider all risks before investing. All decisions are made of your own volition. By using this site, you agree to the following terms set out in the below "Terms of Service" agreement, specifically that Economix101, Inc. (and its affiliates) is not responsible for any sustained losses directly or indirectly associated with this site.

Terms of Service  |  Privacy Policy  |  Social Media

Copyright ©2015-2020 Economix101, Inc. All Rights Reserved.